Varun Govil
Amministratore Delegato presso Epinoma, Inc.
Posizioni attive di Varun Govil
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Epinoma, Inc.
 Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Amministratore Delegato | - | - |
| Direttore Finanziario/CFO | - | - | |
| Segretario Aziendale | - | - | |
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | - | - |
Storia della carriera di Varun Govil
Formazione di Varun Govil
| University of California San Diego | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Chief Executive Officer | 1 |
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
Settori
| Consumer Services | 2 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Epinoma, Inc.
Epinoma, Inc. BiotechnologyHealth Technology Epinoma, Inc. is an early-stage biotechnology company based in San Carlos, CA. The company is developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. The company has received early backing from renowned Harvard geneticist Dr. George Church and has established a strong research collaboration with researchers at TU Dortmund. Epinoma plans to onboard early access liquid biopsy and biopharma customers in late 2022. The CEO of the company is Varun Govil. | Health Technology |
- Borsa valori
- Insiders
- Varun Govil
- Esperienza
